Inhibrx Biosciences (INBX) Retained Earnings (2023 - 2025)
Inhibrx Biosciences (INBX) reported Retained Earnings of -$246.2 million for Q4 2025, down 131.98% year-over-year from $770.0 million in Q4 2024, and down 15.4% quarter-over-quarter from -$213.4 million in Q3 2025.
Inhibrx Biosciences (INBX) Retained Earnings (2023 - 2025) Analysis & Trends
Inhibrx Biosciences (INBX) has 3 years of Retained Earnings data on file, last reported at -$246.2 million in Q4 2025.
- Retained Earnings for Q4 2025 came in at -$246.2 million, down 131.98% year-over-year; the trailing twelve-month figure through Dec 2025 was -$246.2 million (down 131.98% YoY), and the FY2025 annual result was -$246.2 million, down 131.98% from the prior year.
- Retained Earnings slipped to -$246.2 million in Q4 2025 per INBX's latest filing, from -$213.4 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$14.4 million in Q2 2024 and troughed at -$613.7 million in Q4 2023.
- A 3-year average of -$197.5 million and a median of -$163.8 million in 2025 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings soared 82.71% in 2024, then sank 1136.78% in 2025.
- A 3-year view of Retained Earnings shows it stood at -$613.7 million in 2023, then soared by 82.71% to -$106.1 million in 2024, then sank by 131.98% to -$246.2 million in 2025.
- Business Quant data shows INBX's Retained Earnings at -$246.2 million in Q4 2025, -$213.4 million in Q3 2025, and -$178.1 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Inhibrx Biosciences | 186.16 Mn | 186.16 Mn | - | -246.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -246.20 Mn |
| Sep 30, 2025 | -213.35 Mn |
| Jun 30, 2025 | -178.10 Mn |
| Mar 31, 2025 | -149.44 Mn |
| Dec 31, 2024 | -106.13 Mn |
| Sep 30, 2024 | -58.27 Mn |
| Jun 30, 2024 | -14.40 Mn |
| Dec 31, 2023 | -613.73 Mn |